Synagis palivizumab 50mg/0.5 mL Single-Dose Vial Santare chhilaka a leader in ophthalmic solutions

a leader in ophthalmic solutions

and effective results

While this jar is microwave-safe

NDC: 00766-0801-55

or first-aid kit to use in case of emergencies

Synagis palivizumab 50mg/0.5 mL Single-Dose Vial Santare chhilaka a leader in ophthalmic solutionsSynagis palivizumab 50mg 0. 5 mL Single Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections caused by the respiratory syncytial virus (RSV) in infants and children. RSV is a common virus that can lead to severe respiratory infections in young children, particularly those with weakened immune systems. Synagis palivizumab, with its active ingredient 50mg of palivizumab, is administered by injection